Table 1 Summary of patient demographics and clinical/biochemical characteristice (n = 112). All data are expressed as mean (SEM) and number (percentages).
| Â | Reference ranges | |
|---|---|---|
Age (years) | 68.4 ± 0.87 |  |
Age at menopause (years) | 46.6 ± 0.56 |  |
BMI (kg/m 2) | 24.2 ± 0.43 |  |
Current smokers (%) | 21 (18.6) | Â |
Alcohol intake ≤ 14 units/week (%) | 52 (46.4) |  |
Previous fragility Fracture (s) (%) | 68 (60.7) | Â |
Family history of osteoporosis (%) | 27 (24.1) | Â |
Family history of fracture (%) | 20 (17.9) | Â |
History of falls (%) | 31 (27.7) | Â |
Formal exercise (%) | 37 (33.0) | Â |
Walking (≥ 30 minutes/day) (%) | 26 (50.9) |  |
Bisphosphonate treatment duration (years) | 3.81 ± 0.28 |  |
Serum Calcium (nmol/l) | 2.43 ± 0.01 | 2.2–2.6 |
Serum 25(OH) vitamin D (nmol/l) | 70.6 ± 2.86 | 40–195 |
Serum Parathyroid Hormone (ng/l) | 51.6 ± 3.12 | 10–65 |
Urine CTX (μg/mmol creatinine) | 151.3 ± 16.43 | 45–1035 |